4//SEC Filing
Uknis Marc 4
Accession 0001213900-21-020632
CIK 0001816736other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:06 PM ET
Size
5.6 KB
Accession
0001213900-21-020632
Insider Transaction Report
Form 4
Uknis Marc
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-05+277,117→ 277,117 totalExercise: $12.66Exp: 2031-02-04→ Common Stock (277,117 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, February 5, 2021 with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001843161
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:06 PM ET
- Size
- 5.6 KB